ISIN | LU0232583665 |
---|---|
Valor Number | 2304558 |
Bloomberg Global ID | BBG000HSHS81 |
Fund Name | Europe Index -Z EUR |
Fund Provider |
Pictet Asset Management S.A.
Genève, Switzerland Phone: +41 58 323 10 24 www.assetmanagement.pictet |
Fund Provider | Pictet Asset Management S.A. |
Representative in Switzerland |
Pictet Asset Management S.A. Genève 73 Phone: +41 58 323 30 00 |
Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | To achieve a performance comparable to the reference index. The Fund aims for the full physical replication of the MSCI Europe Index (the “Benchmark Index”). |
Peculiarities |
Current Price * | 291.98 EUR | 09.04.2025 |
---|---|---|
Previous Price * | 302.21 EUR | 08.04.2025 |
52 Week High * | 348.60 EUR | 03.03.2025 |
52 Week Low * | 291.98 EUR | 09.04.2025 |
NAV * | 291.98 EUR | 09.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,031,525,162 | |
Unit/Share Assets *** | 174,425,942 | |
Trading Information SIX |
YTD Performance | -6.64% |
31.12.2024 - 09.04.2025
31.12.2024 09.04.2025 |
---|---|---|
YTD Performance (in CHF) | -6.76% |
31.12.2024 - 09.04.2025
31.12.2024 09.04.2025 |
1 month | -13.53% |
10.03.2025 - 09.04.2025
10.03.2025 09.04.2025 |
3 months | -8.27% |
09.01.2025 - 09.04.2025
09.01.2025 09.04.2025 |
6 months | -8.70% |
09.10.2024 - 09.04.2025
09.10.2024 09.04.2025 |
1 year | -4.27% |
09.04.2024 - 09.04.2025
09.04.2024 09.04.2025 |
2 years | +7.55% |
11.04.2023 - 09.04.2025
11.04.2023 09.04.2025 |
3 years | +12.15% |
11.04.2022 - 09.04.2025
11.04.2022 09.04.2025 |
5 years | +62.49% |
09.04.2020 - 09.04.2025
09.04.2020 09.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 13.2028 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 09.04.2025 |
Novo Nordisk AS Class B | 2.51% | |
---|---|---|
SAP SE | 2.50% | |
ASML Holding NV | 2.42% | |
Nestle SA | 2.20% | |
AstraZeneca PLC | 2.03% | |
Roche Holding AG | 2.02% | |
Novartis AG Registered Shares | 1.85% | |
HSBC Holdings PLC | 1.84% | |
Shell PLC | 1.77% | |
Lvmh Moet Hennessy Louis Vuitton SE | 1.72% | |
Last data update | 28.02.2025 |
TER *** | 0.07% |
---|---|
TER date *** | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.00% |
Ongoing Charges *** | 0.08% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |